We're excited to announce the clearance of our IND by the @US_FDA for ABD-147 for the treatment of small cell #lungcancer. Learn more about this next-generation precision #radiopharmaceutical therapy here: https://t.co/9KYxx5uoV8
Interested in ERV's and immunity? Don't miss the next ECI seminar on Tuesday 4/18 at 12pm EST. We'll be hosting Dr. Maria Tokuyama who will be talking about "Crosstalk between endogenous retroviruses and immunity." Should be fantastic.
🇨🇦researchers- this took me 30s. I support increasing federal funding for grad students and postdocs! Join me in sending the message that we care about graduate students and postdoctoral scholars by emailing your Member of Parliament #SupportOurScience https://t.co/I1tmLZzKPm
Excited to announce I successfully defended my PhD this morning on tumour intrinsic mechanisms of T cell suppression in lung cancer. With excellent supervision and guidance along the way from @ninan_abraham1 . Thank you! New doctor in town 👀🥼🧪
Congratulations on a successful PhD defense to Dr. Etienne Melese @melese_mi! Outstanding written and oral defense on tumour intrinsic mechanisms of immune suppression in lung cancer. 🎉🎉👏🏾👏🏾 #ProudPI
August 1st is #WorldLungCancerDay. Although lung cancer rates have dropped in #Canada in the past few decades thanks to years of quit-smoking advocacy and clean air legislation, lung cancer remains the most deadly form of cancer in Canada.
Learn more:
https://t.co/I426iEbBWq
To our M&I community: Do you have an interest in Equity, Diversity and Inclusion (EDI)?
The M&I EDI committee is hosting a luncheon led by Dr. @maria_tokuyama & @melese_mi as part of the new "Let's talk EDI" series.
May 25 at 12pm! Register to join at:
https://t.co/rBCw4uavB1
Happy International Day of #Immunology! We interviewed 3 immunologists from M&I to share their research & what they love about being a scientist. 💚🥼🦠
Julia Lu (@ninan_abraham1 lab), @AbishekWadhwa (Harder lab), & Dr. Lisa Osborne @OsborneLab_UBC!
👉 https://t.co/WSOeigFVG5
Checkout our most recent collaborative publication with @ninan_abraham1 @KevinBennewith @WWL_18 labs Studying how lung tumor cell CCL5 production can lead to an altered immune microenvironment and promote tumor development.
https://t.co/8b7L3uTUTO
Very excited to be a part of this national training platform to contribute to mentoring and #EDI for next generation of scientists #ENRICH . Congratulations to the leadership of @drsamuelcalgary, @richardkeijzer, @ericbenchimol, Dr. Catharine Walsh for this launch.
Excited to present my poster tonight @KeystoneSymp Cancer Immunotherapy: Decoding the Cancer Immunity Interactome. Entitled "Longitudinal alteration to immune response during anti-programmed cell death protein (PD-1) treatment of stage IV non-small cell lung cancer patients"